Microcap Ledger SBC Medical Group Holdings Inc $SBC
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Market
- Sector
- Services-Offices & Clinics of Doctors of Medicine
- Headquarters
- Irvine, CA
- Fiscal year end
- December 31
- Shares outstanding
- 102,846,943 [10-Q 2026-08-13]
What the company doesAI summary of filing
SBC Medical Group Holdings Inc operates a cosmetic clinic management and services business primarily in Japan, with clinics also in Vietnam and Singapore. The company generates revenue through management services agreements with medical corporations (MCs) that operate franchised clinics, as well as through direct operation of clinics in Vietnam and Singapore. The company also holds investments in regenerative medicine and direct-to-consumer health and beauty products through its acquisition of controlling interest in Waqoo, and maintains a minority equity investment in OrangeTwist, a U.S. medical aesthetics company. The company is revenue-generating, reporting financial results primarily in U.S. dollars while earning most revenues and incurring most costs in Japanese yen. [10-K 2026-03-27]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $92.25M | $22.00M | $31.74M | $184.31M | [10-Q 2026-08-13] |
| FY ended Dec 2025 | $173.61M | $50.99M | $24.67M | $163.77M | [10-K 2026-03-27] |
| FY ended Dec 2024 | $205.42M | $46.61M | $20.58M | $125.04M | [10-K 2026-03-27] |
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2025-04-15 | 103,611,251 | [10-K/A 2025-05-09] |
| 2025-04-30 | 103,611,251 | [10-Q 2025-05-15] |
| 2025-07-31 | 103,881,251 | [10-Q 2025-08-13] |
| 2025-10-31 | 102,576,943 | [10-Q 2025-11-14] |
| 2026-02-28 | 102,576,943 | [10-K 2026-03-27] |
| 2026-04-29 | 102,576,943 | [10-K/A 2026-04-30] |
| 2026-05-06 | 102,846,943 | [10-Q 2026-05-14] |
| 2026-07-31 | 102,846,943 | [10-Q 2026-08-13] |
- Shelf registration
- S-3 filed 2025-12-29; declared effective 2025-12-30 [S-3 2025-12-29]
Listing status
Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-07-14. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-07-14 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-07-14] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-04-28 | Aikawa Yoshiyuki | sell | 465,000 | $3.02 | [4 2026-04-29] |
| 2026-04-21 | Aikawa Yoshiyuki | sell | 3,100,000 | $3.02 | [4 2026-04-23] |
| 2026-03-06 | Aikawa Yoshiyuki | sell | 4,422,900 | $2.12 | [4 2026-03-10] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-13 | 10-Q | Quarterly report |
| 2026-08-13 | 8-K | Results of operations; Regulation FD disclosure |
| 2026-07-14 | 8-K | Listing notice or transfer; Change to security holder rights; Charter, bylaws or fiscal year change |
| 2026-05-28 | DEF 14A | Proxy statement |
| 2026-05-20 | 8-K | Director or officer change |
| 2026-05-15 | PRE 14A | Proxy statement |
| 2026-05-14 | 10-Q | Quarterly report |
| 2026-05-14 | 8-K | Results of operations; Regulation FD disclosure |
| 2026-04-30 | 10-K/A | Amended report |
| 2026-04-23 | 8-K | Material agreement entered |
| 2026-04-21 | 13D/A | Beneficial ownership report (5%+ holder) |
| 2026-04-20 | 424B7 | Prospectus or prospectus supplement |
Alerts for $SBC
Email me when SBC Medical Group Holdings Inc files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.